These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 36562715)

  • 1. DRONet: effectiveness-driven drug repositioning framework using network embedding and ranking learning.
    Yang K; Yang Y; Fan S; Xia J; Zheng Q; Dong X; Liu J; Liu Q; Lei L; Zhang Y; Li B; Gao Z; Zhang R; Liu B; Wang Z; Zhou X
    Brief Bioinform; 2023 Jan; 24(1):. PubMed ID: 36562715
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Network-based drug ranking and repositioning with respect to DrugBank therapeutic categories.
    Re M; Valentini G
    IEEE/ACM Trans Comput Biol Bioinform; 2013; 10(6):1359-71. PubMed ID: 24407295
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Computational Drug Repositioning with Random Walk on a Heterogeneous Network.
    Luo H; Wang J; Li M; Luo J; Ni P; Zhao K; Wu FX; Pan Y
    IEEE/ACM Trans Comput Biol Bioinform; 2019; 16(6):1890-1900. PubMed ID: 29994051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NEDD: a network embedding based method for predicting drug-disease associations.
    Zhou R; Lu Z; Luo H; Xiang J; Zeng M; Li M
    BMC Bioinformatics; 2020 Sep; 21(Suppl 13):387. PubMed ID: 32938396
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SNF-NN: computational method to predict drug-disease interactions using similarity network fusion and neural networks.
    Jarada TN; Rokne JG; Alhajj R
    BMC Bioinformatics; 2021 Jan; 22(1):28. PubMed ID: 33482713
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Link Prediction Only With Interaction Data and its Application on Drug Repositioning.
    Liu J; Zuo Z; Wu G
    IEEE Trans Nanobioscience; 2020 Jul; 19(3):547-555. PubMed ID: 32340956
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A geometric deep learning framework for drug repositioning over heterogeneous information networks.
    Zhao BW; Su XR; Hu PW; Ma YP; Zhou X; Hu L
    Brief Bioinform; 2022 Nov; 23(6):. PubMed ID: 36125202
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Novel Drug Repositioning Approach Based on Integrative Multiple Similarity Measures.
    Yan C; Feng L; Wang W; Wang J; Zhang G; Luo J
    Curr Mol Med; 2020; 20(6):442-451. PubMed ID: 31729291
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inferring new indications for approved drugs via random walk on drug-disease heterogenous networks.
    Liu H; Song Y; Guan J; Luo L; Zhuang Z
    BMC Bioinformatics; 2016 Dec; 17(Suppl 17):539. PubMed ID: 28155639
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Time-resolved evaluation of compound repositioning predictions on a text-mined knowledge network.
    Mayers M; Li TS; Queralt-Rosinach N; Su AI
    BMC Bioinformatics; 2019 Dec; 20(1):653. PubMed ID: 31829175
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug Repositioning Based on the Enhanced Message Passing and Hypergraph Convolutional Networks.
    Huang W; Li Z; Kang Y; Ye X; Feng W
    Biomolecules; 2022 Nov; 12(11):. PubMed ID: 36359016
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Computational drug repositioning using meta-path-based semantic network analysis.
    Tian Z; Teng Z; Cheng S; Guo M
    BMC Syst Biol; 2018 Dec; 12(Suppl 9):134. PubMed ID: 30598084
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug-Disease Association Prediction Using Heterogeneous Networks for Computational Drug Repositioning.
    Kim Y; Jung YS; Park JH; Kim SJ; Cho YR
    Biomolecules; 2022 Oct; 12(10):. PubMed ID: 36291706
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Computational drug repositioning using low-rank matrix approximation and randomized algorithms.
    Luo H; Li M; Wang S; Liu Q; Li Y; Wang J
    Bioinformatics; 2018 Jun; 34(11):1904-1912. PubMed ID: 29365057
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HINGRL: predicting drug-disease associations with graph representation learning on heterogeneous information networks.
    Zhao BW; Hu L; You ZH; Wang L; Su XR
    Brief Bioinform; 2022 Jan; 23(1):. PubMed ID: 34891172
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug Repositioning to Accelerate Drug Development Using Social Media Data: Computational Study on Parkinson Disease.
    Zhao M; Yang CC
    J Med Internet Res; 2018 Oct; 20(10):e271. PubMed ID: 30309833
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A network integration approach for drug-target interaction prediction and computational drug repositioning from heterogeneous information.
    Luo Y; Zhao X; Zhou J; Yang J; Zhang Y; Kuang W; Peng J; Chen L; Zeng J
    Nat Commun; 2017 Sep; 8(1):573. PubMed ID: 28924171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In silico drug repositioning based on integrated drug targets and canonical correlation analysis.
    Chen H; Zhang Z; Zhang J
    BMC Med Genomics; 2022 Mar; 15(1):48. PubMed ID: 35249529
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug repositioning using drug-disease vectors based on an integrated network.
    Lee T; Yoon Y
    BMC Bioinformatics; 2018 Nov; 19(1):446. PubMed ID: 30463505
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug Repurposing Using Deep Embeddings of Gene Expression Profiles.
    Donner Y; Kazmierczak S; Fortney K
    Mol Pharm; 2018 Oct; 15(10):4314-4325. PubMed ID: 30001141
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.